• Tuesday, Jun 22, 2021
  • Last Update : 01:44 pm

WHO: No reason to stop using AstraZeneca jab

  • Published at 08:14 pm March 12th, 2021
A Vial of AstraZeneca Vaccine
File Photo: A vial of AstraZeneca coronavirus vaccine is seen at a vaccination centre in Westfield Stratford City shopping centre, in London on February 18, 2021 Reuters

Denmark, Norway, and Iceland paused the use of the AstraZeneca jab as a precaution after isolated reports of recipients developing blood clots

The World Health Organization said on Friday there was no reason to stop using AstraZeneca's Covid-19 vaccine after several countries suspended the rollout over blood clot fears.

The WHO, which said its vaccines advisory committee was examining the safety data coming in, stressed that no causal link had been established between the vaccine and clotting.

The UN health agency also said that after the injection of more than 260 million coronavirus vaccine doses so far around the world, no deaths had yet been attributed to a Covid-19 jab.

Denmark, Norway, and Iceland paused the use of the AstraZeneca jab as a precaution after isolated reports of recipients developing blood clots.

Italy and Austria have banned the use of shots from separate batches of AstraZeneca, and Thailand and Bulgaria said they would delay the rollout of the shot. 

A range of health authorities around the world have insisted the jab is safe, including the European Medicines Agency (EMA) and the WHO.

"AstraZeneca is an excellent vaccine, as are the other vaccines that are being used," WHO spokeswoman Margaret Harris told reporters at a briefing in Geneva.

"Yes, we should continue using the AstraZeneca vaccine," she added, stressing though that any concerns over safety must be investigated.

"We must always ensure that we look for any safety signals when we roll out vaccines, and we must review them," she said.

"But there is no indication to not use it."

No causal link found

The EMA said on Thursday that there had been 30 cases of so-called thromboembolic events among five million people who had received the jab in Europe.

But European countries could still keep using the vaccine, the EU's drug regulator said.

Harris said that while a few countries had, as a precaution, suspended the use of a specific batch of AstraZeneca vaccine distributed in Europe, based on reports of blood coagulation disorders, "a causal relationship has not been shown."

"Vaccination against Covid-19 doesn't reduce deaths from any other causes," she said.

"As of March 9, there have been over 268 million doses of Covid-19 vaccines administered since the start of the pandemic.

"No causes of death have been found to have been caused by Covid-19 vaccines to date."

Harris said the WHO's advisory committee on vaccine safety, which meets at least every two weeks, systematically reviews any safety reports coming in.

"They're currently assessing the reports on AstraZeneca," she said.

Crucial role in Covax

The AstraZeneca-Oxford Covid-19 jab is one of only two to have been given the WHO seal of approval so far.

The organization has granted emergency use listing to the AstraZeneca versions being manufactured in India and South Korea.

The only other Covid-19 vaccine with the WHO green light is that produced by Pfizer/BioNTech.

A decision is expected this month on the single-shot Johnson & Johnson vaccine, while verdicts are due at the earliest in March on China's Sinopharm and Sinovac jabs, along with the Moderna vaccine.

The AstraZeneca jab makes up almost all of the doses being distributed in the first wave of the Covax global vaccine-sharing scheme.

All vaccines deployed via the facility must first be authorized by the WHO.

Some 238.2 million vaccine doses will be distributed to some 142 countries and territories by the end of May through the program, which is aimed at boosting access to coronavirus jabs in poorer nations.

The facility has already shipped more than 20 million doses to 20 countries.

Covax aims to distribute another 14.4 million Covid-19 vaccine doses to 31 more countries this week.

52
Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail